BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37406008)

  • 1. Unified tumor growth mechanisms from multimodel inference and dataset integration.
    Beik SP; Harris LA; Kochen MA; Sage J; Quaranta V; Lopez CF
    PLoS Comput Biol; 2023 Jul; 19(7):e1011215. PubMed ID: 37406008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
    Khan P; Siddiqui JA; Kshirsagar PG; Venkata RC; Maurya SK; Mirzapoiazova T; Perumal N; Chaudhary S; Kanchan RK; Fatima M; Khan MA; Rehman AU; Lakshmanan I; Mahapatra S; Talmon GA; Kulkarni P; Ganti AK; Jain M; Salgia R; Batra SK; Nasser MW
    Mol Cancer; 2023 Jan; 22(1):1. PubMed ID: 36597126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers.
    Wooten DJ; Groves SM; Tyson DR; Liu Q; Lim JS; Albert R; Lopez CF; Sage J; Quaranta V
    PLoS Comput Biol; 2019 Oct; 15(10):e1007343. PubMed ID: 31671086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes.
    Krohn A; Ahrens T; Yalcin A; Plönes T; Wehrle J; Taromi S; Wollner S; Follo M; Brabletz T; Mani SA; Claus R; Hackanson B; Burger M
    PLoS One; 2014; 9(6):e100249. PubMed ID: 24959847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.
    Yu J; Wang S; Zhao W; Duan J; Wang Z; Chen H; Tian Y; Wang D; Zhao J; An T; Bai H; Wu M; Wang J
    Clin Cancer Res; 2018 May; 24(9):2148-2158. PubMed ID: 29437792
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance.
    Jin Y; Chen Y; Qin Z; Hu L; Guo C; Ji H
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(6):948-955. PubMed ID: 37249335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
    Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA
    Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.
    Szeitz B; Megyesfalvi Z; Woldmar N; Valkó Z; Schwendenwein A; Bárány N; Paku S; László V; Kiss H; Bugyik E; Lang C; Szász AM; Pizzatti L; Bogos K; Hoda MA; Hoetzenecker K; Marko-Varga G; Horvatovich P; Döme B; Schelch K; Rezeli M
    Clin Transl Med; 2022 Sep; 12(9):e1060. PubMed ID: 36149789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Regulators Open the Door to SCLC Plasticity.
    Weber MC; Izzo LT; Oliver TG
    Cancer Res; 2023 Nov; 83(21):3495-3497. PubMed ID: 37756567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.
    Kelenis DP; Rodarte KE; Kollipara RK; Pozo K; Choudhuri SP; Spainhower KB; Wait SJ; Stastny V; Oliver TG; Johnson JE
    Cancer Res; 2022 Sep; 82(17):3058-3073. PubMed ID: 35748745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slit2/Robo1 signaling inhibits small-cell lung cancer by targeting β-catenin signaling in tumor cells and macrophages.
    Ahirwar DK; Peng B; Charan M; Misri S; Mishra S; Kaul K; Sassi S; Gadepalli VS; Siddiqui J; Miles WO; Ganju RK
    Mol Oncol; 2023 May; 17(5):839-856. PubMed ID: 35838343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
    Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.
    Chan JM; Quintanal-Villalonga Á; Gao VR; Xie Y; Allaj V; Chaudhary O; Masilionis I; Egger J; Chow A; Walle T; Mattar M; Yarlagadda DVK; Wang JL; Uddin F; Offin M; Ciampricotti M; Qeriqi B; Bahr A; de Stanchina E; Bhanot UK; Lai WV; Bott MJ; Jones DR; Ruiz A; Baine MK; Li Y; Rekhtman N; Poirier JT; Nawy T; Sen T; Mazutis L; Hollmann TJ; Pe'er D; Rudin CM
    Cancer Cell; 2021 Nov; 39(11):1479-1496.e18. PubMed ID: 34653364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
    Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Epithelial-Mesenchymal Transition Genes in Small Cell Lung Cancer Phenotypic Plasticity.
    Groves SM; Panchy N; Tyson DR; Harris LA; Quaranta V; Hong T
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Small Cell Lung Cancer Stem Cells.
    Prabavathy D; Ramadoss N
    Adv Exp Med Biol; 2019; 1139():41-57. PubMed ID: 31134494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organoids as a Systems Platform for SCLC Brain Metastasis.
    Quaranta V; Linkous A
    Front Oncol; 2022; 12():881989. PubMed ID: 35574308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of small cell lung cancer tumor mutation: from molecular mechanisms to novel viewpoints.
    Guan X; Bao G; Liang J; Yao Y; Xiang Y; Zhong X
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):346-355. PubMed ID: 35367118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.
    Chalishazar MD; Wait SJ; Huang F; Ireland AS; Mukhopadhyay A; Lee Y; Schuman SS; Guthrie MR; Berrett KC; Vahrenkamp JM; Hu Z; Kudla M; Modzelewska K; Wang G; Ingolia NT; Gertz J; Lum DH; Cosulich SC; Bomalaski JS; DeBerardinis RJ; Oliver TG
    Clin Cancer Res; 2019 Aug; 25(16):5107-5121. PubMed ID: 31164374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor regulates lineage plasticity driving transformation to small cell lung cancer.
    Jing M; He X; Cai CZ; Ma QZ; Li K; Zhang BX; Yin Y; Shi MS; Wang YS
    Biochem Biophys Res Commun; 2023 Nov; 681():218-224. PubMed ID: 37783120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.